May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Trans–arachidonic acids (TAAs) increase in oxygen induced retinopathy and induce retinal endothelial cell death via a thrombospondin–1–dependent pathwayv
Author Affiliations & Notes
  • F. Sennlaub
    Centre de Recherche, Hopital Ste Justine, Montreal, PQ, Canada
  • E. Kermorvant
    Centre de Recherche, Hopital Ste Justine, Montreal, PQ, Canada
  • M. Balazy
    Centre de Recherche, Hopital Ste Justine, Montreal, PQ, Canada
  • M. Beauchamp
    Centre de Recherche, Hopital Ste Justine, Montreal, PQ, Canada
  • S. Brault
    Centre de Recherche, Hopital Ste Justine, Montreal, PQ, Canada
  • D. Checcin
    Centre de Recherche, Hopital Ste Justine, Montreal, PQ, Canada
  • C. Quiniou
    Centre de Recherche, Hopital Ste Justine, Montreal, PQ, Canada
  • S. Chemtob
    Centre de Recherche, Hopital Ste Justine, Montreal, PQ, Canada
  • Footnotes
    Commercial Relationships  F. Sennlaub, None; E. Kermorvant, None; M. Balazy, None; M. Beauchamp, None; S. Brault, None; D. Checcin, None; C. Quiniou, None; S. Chemtob, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 741. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      F. Sennlaub, E. Kermorvant, M. Balazy, M. Beauchamp, S. Brault, D. Checcin, C. Quiniou, S. Chemtob; Trans–arachidonic acids (TAAs) increase in oxygen induced retinopathy and induce retinal endothelial cell death via a thrombospondin–1–dependent pathwayv . Invest. Ophthalmol. Vis. Sci. 2004;45(13):741.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Nitro–oxidative stress is an important factor in the genesis of retinovascular injury as observed in ROP. But mediators of nitrosative stress remain for the most part unknown. Trans–arachidonic acids (TAAs) are recently described major products of NO2– radical–mediated isomerization of arachidonic acid. We investigated the effects and mode of action of TAAs on newborn retinal microvasculature. Methods: The role of nitrosative products in microvascular degeneration secondary to O2–induced retinopathy was determined by treatment of O2–exposed rat pups with NO2–/ONOO– scavenger FeTPPs. Retinal vascular density was studied after intravitreal injection of TAAs to newborn animals; similar experiments were conducted on retinal explants. In addition, viability of neuroretino–vascular cultured microvascular endothelial, astroglial and smooth muscle cells was determined by MTT (tetrazolium salt 3–(4,5–dimethyl thiazol–2yl)–2,5–diphenyl tetrazolium bromide) assay. Nature of cell death was assessed at different times by propidium iodide incorporation and Annexin V expression (using fluorescence–activated cell sorting). Results: O2–induced retinal vasoobliteration was prevented by the NO2–/ONOO– scavenger FeTPPs; retinal TAA levels rose in this model. Intravitreal injection of TAAs induced a retinal vasoobliteration; these effects were reproduced ex vivo on retinal explants. Clarification of cell type susceptibility was established on cultured neuroretino–vascular cells. TAAs induced a time– and concentration–dependent endothelial cell death; astrocytes, smooth muscle and non–neural endothelial cells were unaffected. The endothelial cell death was consistent with one of necrapoptotic nature. TAAs induced an upregulation of anti–proliferative thrombospondin–1 along with decreased expression of VEGF receptor–2. Moreover, anti–thrombospondin–1 neutralizing antibody completely prevented endothelial cell death. Conclusions: Data uncover new mediators of nitrosative stress in newborn retinal microvascular injury as seen in ROP, namely the TAAs, which in turn exert specific retinal endothelial cytotoxicity via a thrombospondin–1–dependent pathway.

Keywords: oxidation/oxidative or free radical damage • lipids • retinopathy of prematurity 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×